Literature DB >> 20671409

Male sexual disturbances in liver diseases: what do we know?

M Durazzo1, A Premoli, C Di Bisceglie, S Bo, E Ghigo, C Manieri.   

Abstract

The alterations of sexual function known as the erectile dysfunction are quite frequent among patients affected by liver diseases and they tend to increase in advanced liver failure. This process is directly linked to cirrhosis or its treatments, such as liver transplantation, or to certain drugs (e.g. beta-blockers). Independent of cirrhosis, other factors may cause sexual problems in these patients. Alcohol itself seems to worsen sexual function in the absence of cirrhosis. Viral hepatitis has an uncertain influence on male gonadic function and even antiviral therapy itself can worsen some seminal and hormonal parameters, although it is reversible. Quality of life may be greatly decreased in cases of cirrhosis where these alterations are present, so it is important to value and care for them, if possible. This review investigates the major male sexual disturbances in liver diseases of various origins.

Entities:  

Mesh:

Year:  2010        PMID: 20671409     DOI: 10.1007/BF03346632

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  41 in total

1.  Sexual dysfunction in males with chronic hepatitis C and antiviral therapy: interferon-induced functional androgen deficiency or depression?

Authors:  M R Kraus; A Schäfer; T Bentink; M Scheurlen; B Weissbrich; O Al-Taie; J Seufert
Journal:  J Endocrinol       Date:  2005-05       Impact factor: 4.286

2.  Increase of serum estradiol in cirrhotic men treated by transjugular intrahepatic portosystemic stent shunt.

Authors:  W Nolte; C G Schindler; H R Figulla; W Wuttke; M Hüfner; H Hartmann; G Ramadori
Journal:  J Hepatol       Date:  2001-06       Impact factor: 25.083

3.  Frequency and determinants of erectile dysfunction in Italy.

Authors:  F Parazzini; F Menchini Fabris; A Bortolotti; A Calabrò; L Chatenoud; E Colli; M Landoni; M Lavezzari; P Turchi; A Sessa; V Mirone
Journal:  Eur Urol       Date:  2000-01       Impact factor: 20.096

4.  Sexual dysfunction in the United States: prevalence and predictors.

Authors:  E O Laumann; A Paik; R C Rosen
Journal:  JAMA       Date:  1999-02-10       Impact factor: 56.272

5.  Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis B.

Authors:  Elif Doyuk Kartal; Saygin Nayman Alpat; Ilhan Ozgunes; Gaye Usluer
Journal:  Adv Ther       Date:  2007 Sep-Oct       Impact factor: 3.845

6.  Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men.

Authors:  Y J Wang; J C Wu; S D Lee; Y T Tsai; K J Lo
Journal:  Hepatogastroenterology       Date:  1991-12

7.  Presence of HBV DNA in spermatozoa: a possible vertical transmission of HBV via the germ line.

Authors:  M Hadchouel; J Scotto; J L Huret; C Molinie; E Villa; F Degos; C Brechot
Journal:  J Med Virol       Date:  1985-05       Impact factor: 2.327

8.  Erectile dysfunction in end-stage liver disease men.

Authors:  Eric Huyghe; Nassim Kamar; Fabien Wagner; Aude-Hélène Capietto; Labib El-Kahwaji; Fabrice Muscari; Pierre Plante; Lionel Rostaing
Journal:  J Sex Med       Date:  2009-02-04       Impact factor: 3.802

9.  Recovery of sexual function in abstinent alcoholic men.

Authors:  D H Van Thiel; J S Gavaler; A Sanghvi
Journal:  Gastroenterology       Date:  1983-04       Impact factor: 22.682

10.  Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C.

Authors:  Lorna M Dove; Raymond C Rosen; Darmendra Ramcharran; Abdus S Wahed; Steven H Belle; Robert S Brown; Jay H Hoofnagle
Journal:  Gastroenterology       Date:  2009-06-13       Impact factor: 22.682

View more
  6 in total

1.  The combined polymorphisms of interleukin-6-174GG genotype and interleukin-10 ATA haplotype are associated with a poor quality of life in patients with chronic hepatitis C.

Authors:  Diego Alves Vieira; Luciana Rodrigues da Cunha; Cliviany Borges da Silva; Maria Thereza Bastos Almeida; Adriana Dias Gomes; César Lúcio Lopes de Faria; Rosângela Teixeira; Fernando Silva Neves; Gifone Aguiar Rocha; Fabrício Freire de Melo; Dulciene Maria de Magalhães Queiroz; Luciana Diniz Silva
Journal:  Qual Life Res       Date:  2019-02-07       Impact factor: 4.147

2.  Erectile Dysfunction in Cirrhosis: Its Prevalence and Risk Factors.

Authors:  Rakesh K Jagdish; Ahmed Kamaal; Saggere M Shasthry; Jaya Benjamin; Rakhi Maiwall; Ankur Jindal; Ashok Choudhary; Vijayaraghavan Rajan; Vinod Arora; Ankit Bhardwaj; Guresh Kumar; Manoj Kumar; Shiv K Sarin
Journal:  J Clin Exp Hepatol       Date:  2022-05-10

3.  Causes of erectile dysfunction in non-alcoholic fatty liver disease.

Authors:  Haluk Tarik Kani; Tarik Emre Sener; Umut Emre Aykut; Coskun Ozer Demirtas; Caglayan Keklikkiran; Ilkay Ergenc; Abdullah Fatih Demirci; Haydar Kamil Cam; Cigdem Celikel; Cem Akbal; Deniz Duman
Journal:  Hepatol Forum       Date:  2021-05-24

Review 4.  [Urological aspects in patients with liver cirrhosis].

Authors:  A Friedl; R Schwarzer; J Schneeweiss; C Brössner
Journal:  Urologe A       Date:  2016-01       Impact factor: 0.639

5.  Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.

Authors:  Rafael Paternostro; Birgit B Heinisch; Thomas Reiberger; Mattias Mandorfer; Remy Schwarzer; Berit Seeland; Michael Trauner; Markus Peck-Radosavljevic; Arnulf Ferlitsch
Journal:  Liver Int       Date:  2018-02-20       Impact factor: 5.828

6.  Erectile function in men with end-stage liver disease improves after living donor liver transplantation.

Authors:  You-Chiuan Chien; Heng-Chieh Chiang; Ping-Yi Lin; Yao-Li Chen
Journal:  BMC Urol       Date:  2015-08-13       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.